MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
MLTX Stock Analysis: Buy, Sell, or Hold?
$13.69
+1.13 (+9.00%)
▲
5d:
+18.43%
30d:
+31.51%
90d:
-17.03%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect MLTX Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$10.34 – $12.30
Position: EXTENDED
Forward P/E & Valuation
-3.7x
Next 12M consensus est.
Wall Street Target
$30.29
+141.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.67 / $13.88
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: MLTX is 11.3% above its trading range ($12.30). While momentum could continue, risk/reward favors waiting for a pullback.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 6, 2026 at $11.49 · last confirmed Nov 10, 2026
Strength: 4.6/10
Get Alerted When MLTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MLTX is currently trading at $13.69, which is considered extended relative to its 30-day fair value range of $10.34 to $12.30.
Technical Outlook: Technically, MLTX is in a strong downtrend. The price is approaching resistance at $13.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: MLTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.29 (+141.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MLTX is in a strong downtrend. The price is approaching resistance at $13.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.0% recently.
Market Sentiment: MLTX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.29 (+141.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.34 -
$12.30
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$10.34 -
$12.30
Current vs Trading Range
EXTENDED
Support Level
$10.67
Resistance Level
$13.88
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding MLTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.0%)
- BULLISH: Trading 141.1% below Wall St target ($30.29)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.70
Wall Street Target
$30.29
(+141.1%)
Share MLTX Analysis
Share this live MLTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MLTX)
Bullish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
MoonLake Immunotherapeutics (MLTX) reported a net loss in Q3 2026, focusing on sonelokimab regulatory milestones. Bulls argue undervalued due to sonelokimab potential, while bears point to heavy losses.
Key Retail Themes:
MoonLake Immunotherapeutics financial results
sonelokimab regulatory milestones
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 3:09 PM ET
Data refreshes hourly during market hours. Next update: 4:09 PM
Data refreshes hourly during market hours. Next update: 4:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 63 BUY |
Advanced MLTX Option Strategies
Professional options setups generated by AI based on today's MLTX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MLTX Research Pages
